RxSight (RXST) Short Interest Ratio & Short Volume → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free RXST Stock Alerts $60.65 -1.61 (-2.59%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media RxSight Short Interest DataCurrent Short Volume1,570,000 sharesPrevious Short Volume1,470,000 sharesChange Vs. Previous Month+6.80%Dollar Volume Sold Short$81.84 millionShort Interest Ratio / Days to Cover3.8Last Record DateApril 30, 2024Outstanding Shares36,990,000 sharesFloat Size31,300,000 sharesShort Percent of Float5.02%Today's Trading Volume329,785 sharesAverage Trading Volume494,398 sharesToday's Volume Vs. Average67% Short Selling RxSight ? Sign up to receive the latest short interest report for RxSight and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatRXST Short Interest Over TimeRXST Days to Cover Over TimeRXST Percentage of Float Shorted Over Time Ad Porter & CompanyElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. RxSight Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20241,570,000 shares $81.84 million +6.8%5.0%3.8 $52.13 4/15/20241,470,000 shares $78.29 million +14.0%4.7%3.7 $53.26 3/31/20241,290,000 shares $66.54 million -0.8%4.2%2.9 $51.58 3/15/20241,300,000 shares $61.35 million +5.7%4.2%2.8 $47.19 2/29/20241,230,000 shares $67.12 million -5.4%4.0%2.4 $54.57 2/15/20241,300,000 shares $69.62 million -10.3%4.3%2.5 $53.55 Get the Latest News and Ratings for RXST and Related StocksEnter your email address below to receive the latest news and analysts' ratings for RxSight and its competitors with MarketBeat's FREE daily newsletter. 1/31/20241,450,000 shares $65.99 million +21.9%4.8%2.6 $45.51 1/15/20241,190,000 shares $55.18 million +19.4%4.0%2 $46.37 12/31/2023996,400 shares $40.17 million -9.4%3.3%1.7 $40.32 12/15/20231,100,000 shares $43.68 million -16.7%3.7%2.1 $39.71 11/30/20231,320,000 shares $39.81 million +0.8%4.5%2.6 $30.16 11/15/20231,310,000 shares $35.99 million -9.7%4.6%2.8 $27.47 10/31/20231,450,000 shares $32.10 million +2.1%5.2%3.2 $22.14 10/15/20231,420,000 shares $34.38 million -1.4%5.1%3.2 $24.21 9/30/20231,440,000 shares $40.16 million +35.9%5.1%3.2 $27.89 9/15/20231,060,000 shares $31.62 million -24.8%3.8%2.3 $29.83 8/31/20231,410,000 shares $40.90 million -1.4%5.1%2.9 $29.01 8/15/20231,430,000 shares $43.67 million +3.6%5.2%2.9 $30.54 7/31/20231,380,000 shares $46.05 million +1.5%5.6%2.8 $33.37 7/15/20231,360,000 shares $44.13 million +27.1%5.8%3.1 $32.45 6/30/20231,070,000 shares $30.82 million +28.5%4.5%2.6 $28.80 6/15/2023832,700 shares $21.39 million +22.6%3.5%2.2 $25.69 5/31/2023679,300 shares $16.55 million +16.2%2.9%2.1 $24.37 5/15/2023584,600 shares $13.24 million -9.8%2.6%2.2 $22.64 4/30/2023647,800 shares $11.60 million +35.5%2.9%3.1 $17.90 4/15/2023478,100 shares $8.41 million -1.2%2.1%2.9 $17.59 3/31/2023483,800 shares $8.07 million +20.9%2.1%3.3 $16.68 3/15/2023400,100 shares $5.98 million -1.3%2.0%3 $14.95 2/28/2023405,200 shares $5.56 million +3.2%2.0%3.9 $13.72 2/15/2023392,700 shares $5.43 million -15.2%2.6%4.6 $13.84 1/31/2023462,900 shares $6.48 million +12.3%3.0%5.7 $14.00 1/15/2023412,400 shares $5.39 million -4.0%2.6%6 $13.08 12/30/2022429,500 shares $5.44 million +3.3%2.8%6.4 $12.67 12/15/2022415,700 shares $5.01 million -4.8%2.7%6.7 $12.05 11/30/2022436,600 shares $5.58 million -16.3%2.8%6.5 $12.77 11/15/2022521,500 shares $7.08 million -7.7%3.4%7.9 $13.57 10/31/2022564,800 shares $7.03 million -0.1%3.7%7.4 $12.44 10/15/2022565,400 shares $5.79 million -13.0%3.7%7.3 $10.24 9/30/2022650,000 shares $7.80 million +39.1%4.3%8.7 $12.00 9/15/2022467,400 shares $5.98 million +10.7%3.1%5.8 $12.80He called Apple at $1.49 and now he says: “Buy these 6 AI stocks.” (Ad)For over four decades, Louis Navellier has found the very best tech stocks... Before the rest of the market.Click for his six specific AI stock in the crosshairs RXST Short Interest - Frequently Asked Questions What is RxSight's current short interest? Short interest is the volume of RxSight shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 1,570,000 shares of RXST short. 5.02% of RxSight's shares are currently sold short. Learn More on RxSight's current short interest. What is a good short interest ratio for RxSight? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RXST shares currently have a short interest ratio of 4.0. Learn More on RxSight's short interest ratio. What is a good short interest percentage for RxSight? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.02% of RxSight's floating shares are currently sold short. Is RxSight's short interest increasing or decreasing? RxSight saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 1,570,000 shares, an increase of 6.8% from the previous total of 1,470,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is RxSight's float size? RxSight currently has issued a total of 36,990,000 shares. Some of RxSight's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. RxSight currently has a public float of 31,300,000 shares. How does RxSight's short interest compare to its competitors? 5.02% of RxSight's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to RxSight: STAAR Surgical (9.02%), Bausch Health Companies Inc. (5.73%), Warby Parker Inc. (12.43%), National Vision Holdings, Inc. (9.28%), Edap Tms S.A. (0.32%), ClearPoint Neuro, Inc. (4.96%), Neuronetics, Inc. (0.19%), Apyx Medical Co. (1.90%), Bausch + Lomb Co. (4.65%), Vera Therapeutics, Inc. (16.61%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short RxSight stock? Short selling RXST is an investing strategy that aims to generate trading profit from RxSight as its price is falling. RXST shares are trading down $1.61 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against RxSight? A short squeeze for RxSight occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RXST, which in turn drives the price of the stock up even further. How often is RxSight's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RXST, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: STAAR Surgical Short Interest Bausch Health Companies Short Interest Warby Parker Short Interest National Vision Short Interest Edap Tms Short Interest ClearPoint Neuro Short Interest Neuronetics Short Interest Apyx Medical Short Interest Bausch + Lomb Short Interest Vera Therapeutics Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RXST) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaMissed NVDA? Buy this AI stock NOWChaikin AnalyticsUrgent Nvidia WarningAltimetryCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMost important medical advance in 100 yearsThe Oxford ClubNext President (Not Trump. Not Biden.)The Freeport SocietyCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceProtect Your Bank Account Before It’s Too LateWeiss Ratings